Eribulin and Confusion: A Previously Unknown Drug Side-Effect
Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman trea...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2020-06-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1708 |
_version_ | 1818043027165282304 |
---|---|
author | Abu Baker Sheikh Abhilash Perisetti Nismat Javed Rahul Shekhar |
author_facet | Abu Baker Sheikh Abhilash Perisetti Nismat Javed Rahul Shekhar |
author_sort | Abu Baker Sheikh |
collection | DOAJ |
description | Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration. |
first_indexed | 2024-12-10T08:55:41Z |
format | Article |
id | doaj.art-0012887f0a494954a44cbc3870c2cccb |
institution | Directory Open Access Journal |
issn | 2284-2594 |
language | English |
last_indexed | 2024-12-10T08:55:41Z |
publishDate | 2020-06-01 |
publisher | SMC MEDIA SRL |
record_format | Article |
series | European Journal of Case Reports in Internal Medicine |
spelling | doaj.art-0012887f0a494954a44cbc3870c2cccb2022-12-22T01:55:26ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942020-06-0110.12890/2020_0017081343Eribulin and Confusion: A Previously Unknown Drug Side-EffectAbu Baker Sheikh0Abhilash Perisetti1Nismat Javed2Rahul Shekhar3Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USADepartment of Gastroenterology, University of Arkansas for Medical Sciences, Little Rock, AR, USADepartment of Internal Medicine, Shifa College of Medicine, Islamabad, PakistanDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USAEribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration.https://www.ejcrim.com/index.php/EJCRIM/article/view/1708eribulinencephalopathybreast cancer |
spellingShingle | Abu Baker Sheikh Abhilash Perisetti Nismat Javed Rahul Shekhar Eribulin and Confusion: A Previously Unknown Drug Side-Effect European Journal of Case Reports in Internal Medicine eribulin encephalopathy breast cancer |
title | Eribulin and Confusion: A Previously Unknown Drug Side-Effect |
title_full | Eribulin and Confusion: A Previously Unknown Drug Side-Effect |
title_fullStr | Eribulin and Confusion: A Previously Unknown Drug Side-Effect |
title_full_unstemmed | Eribulin and Confusion: A Previously Unknown Drug Side-Effect |
title_short | Eribulin and Confusion: A Previously Unknown Drug Side-Effect |
title_sort | eribulin and confusion a previously unknown drug side effect |
topic | eribulin encephalopathy breast cancer |
url | https://www.ejcrim.com/index.php/EJCRIM/article/view/1708 |
work_keys_str_mv | AT abubakersheikh eribulinandconfusionapreviouslyunknowndrugsideeffect AT abhilashperisetti eribulinandconfusionapreviouslyunknowndrugsideeffect AT nismatjaved eribulinandconfusionapreviouslyunknowndrugsideeffect AT rahulshekhar eribulinandconfusionapreviouslyunknowndrugsideeffect |